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In England in 2015, Shigella sonnei isolates from men 
who have sex with men produced extended-spectrum 
β-lactamases and exhibited macrolide resistance. Whole-
genome sequencing showed a close relationship among 
the isolates, which harbored a plasmid that was previously 
identified in a shigellosis outbreak among this population 
but has acquired a mobile element. 
Historically, shigellosis is an infection associated with travel to countries in which this infection is endemic. 
In England in 2009, Shigella flexneri 3a infections dramati-
cally increased among men who have sex with men (MSM) 
and were thought to be associated with sexual transmission 
(1). Since 2011, an emerging epidemic of S. sonnei infec-
tions in England among men has occurred (2). We describe 
an investigation of a cluster of multidrug-resistant S. sonnei 
infections among MSM in England during 2015.
The Study
In November 2015, Public Health England (PHE) iden-
tified a cluster of S. sonnei isolates by analyzing whole-
genome sequencing data from specimens collected during 
September and October from 4 adult men residing in Lon-
don and having no known travel history. Clinical reporting 
data indicated that 2 of the men were MSM. The isolates 
were later found to exhibit high levels of antimicrobial drug 
resistance to amoxicillin, ceftriaxone, tetracycline, sulfon-
amides, trimethoprim, and azithromycin and to produce 
extended-spectrum β-lactamase (ESBL) (Table 1). The iso-
lates were sensitive to quinolones. PHE convened an out-
break control team to identify additional cases, characterize 
cases, capture exposure information, rule out a point source 
for the outbreak, and provide evidence for additional tar-
geted public health efforts.
Since August 2015, PHE has conducted whole-ge-
nome sequencing of ≈70% of S. sonnei isolates (those 
voluntarily referred from hospital laboratories) (on-
line Technical Appendix, http://wwwnc.cdc.gov/EID/
article/22/11/16-0653-Techapp1.pdf). Single nucleotide 
polymorphism (SNP) clustering is performed, as previ-
ously described (3). Readings (in FASTQ format) from 
all sequences in this study can be found at the PHE Patho-
gens BioProject (National Center for Biotechnology In-
formation project no. PRJNA315192).
DNA from isolate 183660 was used to elucidate 
plasmid sequencing (online Technical Appendix). The 
multidrug-resistance phenotype was explained by the pres-
ence of an 89,000-bp IncFII plasmid designated p183660 
(GenBank accession no. KX008967). This plasmid had 
>95% nt identity to pKSR100, a multidrug-resistance plas-
mid from an MSM case of S. flexneri 3a infection (Gen-
Bank accession no. LN624486) that had acquired the previ-
ously described pKSR100 integron (blaTEM-1, dfrA17, dfrA1, 
sul1, aadA5) (4) and a novel mobile element harboring 
blaCTX-M-27 (Figure 1). Macrolide resistance was conferred 
by ermB and mphA.
For this investigation, we defined a case-patient as a 
resident of England with laboratory-confirmed S. sonnei in-
fection belonging to a 5 SNP cluster with the SNP address 
1.3.3.9.207.212.%, a resistance profile characterized by the 
presence of the plasmid p183660, and a specimen collected 
during September 1, 2015–February 29, 2016. We identi-
fied 9 case-patients (Figure 2) from fecal specimens; all 
had no known travel history in the 2 weeks before illness. 
Median age was 33 (range 28–83) years. Gastrointestinal 
symptom onset ranged from early September 2015 to late 
December 2015. No patients were bacteremic. Treatment 
failure was reported for 2 patients; both were hospitalized 
and 1 died, although Shigella was not recorded as a cause 
of death. Duration of illness was not systematically collect-
ed. Diagnoses occurred in general practice (n = 5), sexual 
health clinics (n = 2), and hospitals (n = 2). Seven patients 
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resided in London; 2 resided elsewhere in England, 1 of 
whom reported recent travel to London. Of 8 patients with 
reported ethnicity, 6 self-identified as white.
In-depth questionnaires administered by telephone 
interviews collected information on sexual history, food 
exposures, and travel history; 8 patients completed the in-
terviews. Seven answered detailed sexual history questions 
(including the 2 patients identified as MSM from clinical 
reporting data); all 7 reported having male partners. Six re-
ported exposures considered to be high risk for Shigella 
transmission during the incubation period (e.g., fisting, 
sex under the influence of recreational drugs [6], oral-anal 
contact, attendance at sex parties, or use of sex toys with 
a partner) (Table 2). Reported number of sexual partners 
during the 2 weeks before illness was 0–5. The 7 patients 
who completed the sexual history questions reported previ-
ous high-risk sexual exposures; 6 of these patients and 1 
patient who partially completed the questionnaire reported 
a history of other sexually transmitted infections, includ-
ing gonorrhea, chlamydia, syphilis, nonspecific urethritis, 
hepatitis C, and pubic lice. Five reported using mobile apps 
to meet partners at some time in the past; none reported 
a prior shigellosis diagnosis. All had visited sexual health 
services (Table 2). Some patients were HIV positive (fre-
quency is omitted to prevent deductive disclosure). 
No epidemiologic links were identified among patients, 
and no point sources were identified, although food exposure 
data was collected for 5 patients only. Two reported attend-
ing the same sex-on-premises venue in London 3 months 
apart (1 reported no sexual contact at the venue). None 




Table 1. Results of the phenotypic antimicrobial drug resistance profile of 4 isolates of Shigella sonnei, England, 2015* 
Isolate 
ID 
MIC for antimicrobial drugs tested, μg/mL† 
AMP AMC CTX CRO CAZ CFP GEN TOB TMP SEP ATM CIP COL ERT MER FOS TEM AZT 
182834 >1,052 1 >32 >32 2 0.38 0.5 0.38 >32 64 0.38 <0.032 0.19 0.008 0.06 1 <1 >256 
184494 >1,052 1 >32 >32 2 0.5 0.38 0.38 >32 128 0.5 <0.032 0.125 0.008 0.06 1.5 <1 >256 
183660 >1,052 1 >32 >32 1 0.38 0.38 0.38 >32 128 0.38 <0.032 0.125 0.008 0.06 1 <1 >256 
164679 >1,052 1 >32 >32 1 0.38 0.38 0.38 >32 64 0.38 <0.032 0.19 0.008 0.06 1 <1 >256 
*TEM was included in the panel to aid detection of OXA-48–like carbapenemases. AMC, amoxicillin/clavulanate; AMP, ampicillin; ATM, aztreonam; AZT, 
azithromycin; CAZ, ceftazidime; CFP, cefepime; CIP, ciprofloxacin; COL, colistin;  CRO, ceftriaxone; CTX, cefotaxime; ERT, ertapenem; FOS, fosfomycin; 
GEN, gentamicin; ID, identification; MER, meropenem; SEP, trimethoprim/sulfamethoxazole; TEM, temocillin; TMP, trimethoprim; TOB, tobramycin.  
†Phenotypic antimicrobial drug susceptibility testing was performed by using Etest (bioMérieux, Marcy l’Etoile, France) and interpreted by using 
breakpoints for Enterobacteriaceae established by the European Committee on Antimicrobial Susceptibility Testing (http://www.eucast.org/). Production of 
extended-spectrum β-lactamase was confirmed by using CTX + clavulunic acid and CAZ + clavalunic acid in combination (bioMérieux). 
 
Figure 1. Genomic plot of 
multidrug-resistance plasmid 
p183660 (inner ring, blue) from 
a man in England infected with 
Shigella sonnei compared with 
pKSR100 (outer ring, purple), a 
multidrug-resistance plasmid from 
a case of S. flexneri 3a infection 
occurring among men who have 
sex in men (4). Drug-resistant 
elements from p183660 are shown 
in red. Plot produced by using 
BLAST Ring Image Generator (5).
DISPATCHES
reported awareness of possible infection with Shigella spp. 
or of contact with others with gastrointestinal symptoms. 
Three thought they had acquired their infections from food. 
Patients reported that they accessed health promotion mes-
sages at sexual health clinics and on the internet.
Conclusions
We describe a phylogenetic cluster of ESBL-producing S. 
sonnei infections in MSM in England that raises concerns 
about the ability to manage the spread of resistant Shigella 
infection in this population. Whole-genome sequencing re-
vealed that the multidrug-resistance phenotype is conferred 
by acquisition of an IncFII plasmid (p183660) known to be 
circulating in S. flexneri–affected MSM (4); this plasmid 
has acquired blaCTX-M-27.
Patient-reported behaviors were similar to those re-
ported in an earlier S. flexneri epidemic among MSM: high 
numbers of sexual partners, high levels of condomless sex, 
attendance at sex parties, sex under the influence of recre-
ational drugs, and prior HIV infection (6). We identified no 
point source, further indicating that sexual contact was the 
dominant mode of transmission.
Although S. sonnei causes self-limiting diarrhea in 
most patients, life-threatening invasive infections in pa-
tients co-infected with HIV have occurred (7). Quinolone 
and azithromycin resistance have been observed in recent 
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Figure 2. Maximum-likelihood phylogeny showing isolates from a cluster of 9 cases (gray shading) of Shigella sonnei infection among 
men who have sex with men in England, 2015. For context, 246 S. sonnei isolates that are representatives from each t25 cluster were 
included in the comparison. Isolates are labeled by single nucleotide polymorphism address.
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outbreaks of S. sonnei infections in MSM; cepaholsporins 
are recognized as a suitable therapeutic choice for invasive 
or prolonged infections (8,9).
Primary public health concerns include possible treat-
ment failure for severe shigellosis in immunocompromised 
patients; further spread of the multidrug-resistant IncFII plas-
mid to other enteric pathogens in MSM, with possible impli-
cations for treatment among the immunocompromised; rapid 
spread of drug-resistant S. sonnei infections among MSM, 
including outside the United Kingdom, as happened with 
S. flexneri 3a (4), especially among the HIV infected; and 
transmission through food handling and childcare centers, 
with potential to cause outbreaks of drug-resistant S. sonnei 
infections in other populations. Low awareness of Shigella 
infections among patients in our study suggests that prior 
awareness campaigns targeting high-risk MSM in England 
(10) have not been fully successful. Future campaigns being 
planned to improve awareness of Shigella infection and trans-
mission routes will target social media, sexual health clin-
ics, and primary care workers to increase awareness among 
MSM and healthcare staff. Frontline sexual health clinicians 
and microbiologists in England have been made aware of 
emerging drug resistance in Shigella spp. among this vulner-
able group and of the need to perform antimicrobial drug sus-
ceptibility testing if treatment is considered necessary.
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